Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
BUILD THERAPEUTICS ApS
APS
Dissolved
CVR 35400060
Nordvej 16B, 4000
Roskilde
Forskning og eksperimentel udvikling indenfor bioteknologi
·
NACE 721100
Est. 2013 · 13 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Forskning og eksperimentel udvikling indenfor bioteknologi
/
BUILD THERAPEUTICS ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (2)
SN
Søren Nyboe Jakobsen
Deputy
Deputy
2013 – 2017
MD
Mikkel Dybro Lundorf
Chief Executive Officer
Chief Executive Officer
2013 – 2017
Board of directors
Non-executive oversight
Name
Role
Member since
Former (2)
SN
Søren Nyboe Jakobsen
Chairman
Chairman
2013 – 2017
MD
Mikkel Dybro Lundorf
Deputy Chairman
Deputy Chairman
2013 – 2017
Shareholders
As of last annual report
SPIRO HOLDING ApS — 50–66.65%
MOLIOR HOLDING ApS — 33.33–49.99%
83–100%
Shareholder
Type
Ownership
Votes
Since
SPIRO HOLDING ApS
Company
50–66.65%
50–66.65%
2013
MOLIOR HOLDING ApS
Company
33.33–49.99%
33.33–49.99%
2013
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on BUILD THERAPEUTICS ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network